Previous close | 47.84 |
Open | 47.64 |
Bid | 19.25 x 800 |
Ask | 57.13 x 800 |
Day's range | 47.32 - 48.65 |
52-week range | 21.06 - 66.47 |
Volume | |
Avg. volume | 497,810 |
Market cap | 2.484B |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.79 |
Earnings date | 23 Feb 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 84.60 |
DUBLIN, Ireland, March 21, 2023--Prothena announced today that members of its senior management team will participate in a fireside chat at Stifel 2023 Virtual CNS Days on March 28 .
DUBLIN, March 14, 2023--Prothena announced broad participation at AD/PD 2023 highlighting leadership in advancing treatments for Alzheimer’s and Parkinson’s disease
Prothena (PRTA) reports better-than-expected results for the fourth quarter. The company makes considerable pipeline progress.